TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35064063

Group type: EXPERIMENTAL
Intervention: Social media campaign for mothers aimed at reducing indoor tanning (IT)
Number of subjects: 869

Group type: COMPARATOR
Intervention: Prescription drug misuse campaign (control)
Number of subjects: 869
Study: 34719829

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 200
Study: 32471854

Group type: EXPERIMENTAL
Intervention: Fast-acting treatment (BeSt and IMPROVED)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Slow-acting treatment (BeSt)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Slow-acting monotherapy
Number of subjects: 987

Group type: COMPARATOR
Intervention: Fast-acting treatment (BeSt)
Number of subjects: 987

Group type: COMPARATOR
Intervention: Fast-acting treatment (IMPROVED)
Number of subjects: 987
Study: 36161306

Group type: EXPERIMENTAL
Intervention: Vigabatrin (2g/day for 4 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34765938

Group type: EXPERIMENTAL
Intervention: Early access to antiretroviral therapy (ART)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Late access to antiretroviral therapy (ART)
Number of subjects: 240
Study: 36075590

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with intradermal needling
Number of subjects: 116

Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups (after treatment)
Number of subjects: 116
Study: 36135347

Group type: EXPERIMENTAL
Intervention: Hypobaric unilateral spinal anesthesia (HUSA)
Number of subjects: 154

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 154
Study: 32897010

Group type: EXPERIMENTAL
Intervention: Antibacterial therapy (ABT) + recombinant interferon alpha‐2b with antioxidant complex (vitamins E and C)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Antibacterial therapy (ABT)
Number of subjects: 62
Study: 35270910

Group type: EXPERIMENTAL
Intervention: Active stimulation (AAA) with the same coil for test‐treat‐test phases (n = 22)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Active coil stimulation for tests and placebo coil stimulation for treatment (APA) (n = 15)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Realistic placebo coil stimulation for all three phases (PPP) (n = 10)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Active stimulation (AAA)
Number of subjects: 47
Study: 32540320

Group type: EXPERIMENTAL
Intervention: Medial canting wedges
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lateral canting wedges
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unmodified ski boots (control)
Number of subjects: 38
Study: 33520912

Group type: EXPERIMENTAL
Intervention: Participants aged 45-54 years
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Participants living in Barranquilla
Number of subjects: 1135
Study: 35842871

Group type: COMPARATOR
Intervention: Control arm of the AVAglio trial (NCT00943826)
Number of subjects: 169
Study: 32291164

Group type: EXPERIMENTAL
Intervention: ACLS Clinical Decision Display System (CDDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No CDDS (control)
Number of subjects: 0
Study: 35177653

Group type: COMPARATOR
Intervention: ERM[08-10]
Number of subjects: 100

Group type: COMPARATOR
Intervention: DG and UDA
Number of subjects: 100
Study: 34759043

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 1096
Study: 32299820

Group type: EXPERIMENTAL
Intervention: Low-dose carfilzomib (27 mg/m2) with dexamethasone
Number of subjects: 121

Group type: COMPARATOR
Intervention: High-dose carfilzomib (56 mg/m2) with dexamethasone
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Crossover to high-dose carfilzomib (56 mg/m2) after progression on low-dose
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 121

Group type: COMPARATOR
Intervention: High-dose carfilzomib (56 mg/m2)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Low-dose carfilzomib (27 mg/m2)
Number of subjects: 121
Study: 35452354

Group type: EXPERIMENTAL
Intervention: Non-absorbable (polyester) suture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Absorbable (vicryl) suture
Number of subjects: 40
Study: 32265061

Group type: EXPERIMENTAL
Intervention: DJT1116PG 20 mg once daily for 7 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DJT1116PG 50 mg once daily for 7 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DJT1116PG 100 mg once daily for 7 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DJT1116PG (all doses)
Number of subjects: 36

Group type: COMPARATOR
Intervention: DJT1116PG
Number of subjects: 36
Study: 35067389

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (2 μg/kg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (intranasal water)
Number of subjects: 49
Study: 33495576

Group type: EXPERIMENTAL
Intervention: rhEPO 500 IU/mL plus methylprednisolone (M + E group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: methylprednisolone (M group)
Number of subjects: 54
Study: 36184724

Group type: COMPARATOR
Intervention: Control group (no radiographs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 2D group (placement with 2D radiographs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: CBCT group (placement with CBCT)
Number of subjects: 15
Study: 34118436

Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ovulatory phase
Number of subjects: 9
Study: 32284389

Group type: EXPERIMENTAL
Intervention: SELF course (25-hour course in nutritional counselling)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard medical curriculum (comparison group)
Number of subjects: 118
Study: 36306708

Group type: EXPERIMENTAL
Intervention: Just in Time ergonomic teaching (n = 8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Just in Time ergonomic teaching
Number of subjects: 14
Study: 33806189

Group type: EXPERIMENTAL
Intervention: Fixed prostheses supported by zygomatic implants (2–4 zygomatic and 2–4 conventional implants)
Number of subjects: 80

Group type: COMPARATOR
Intervention: All-on-four concept (fixed prostheses on four implants)
Number of subjects: 80
Study: 32493256

Group type: EXPERIMENTAL
Intervention: Healthcare voucher (HcV) model
Number of subjects: 396

Group type: COMPARATOR
Intervention: Electronic health card (eHC) model
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Both models
Number of subjects: 396
Study: 33810585

Group type: EXPERIMENTAL
Intervention: Overexpression of Pto-CPCa in Arabidopsis thaliana
Number of subjects: 1749

Group type: EXPERIMENTAL
Intervention: Overexpression of PtoWRKY13 in Arabidopsis thaliana
Number of subjects: 1749
Study: 33038494

Group type: EXPERIMENTAL
Intervention: Augmented medial rectus recession
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medial rectus recession with posterior scleral fixation
Number of subjects: 60
Study: 36107485

Group type: EXPERIMENTAL
Intervention: Pre-chemotherapy NLR
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: ΔNLR attenuation during NAC
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: NLR score = pre-chemotherapy NLR + ΔNLR
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: NLR-attenuating anti-Ly6G treatment with gemcitabine/paclitaxel
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Neutrophil-derived IL-1β
Number of subjects: 94
Study: 34499667

Group type: EXPERIMENTAL
Intervention: 3D virtual reality environment
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D virtual reality environment
Number of subjects: 40
Study: 33593774

Group type: EXPERIMENTAL
Intervention: Web-based behavioural lifestyle programme with 12 months of access to EBPI about lifestyle factors in MS, combined with a complex behaviour change programme
Number of subjects: 328

Group type: COMPARATOR
Intervention: Optimised standard care
Number of subjects: 328
Study: 32240383

Group type: EXPERIMENTAL
Intervention: Robotic distal pancreatectomy (RDP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Laparoscopic distal pancreatectomy (LDP)
Number of subjects: 103
Study: 35639038

Group type: EXPERIMENTAL
Intervention: Canagliflozin and irbesartan
Number of subjects: 132

Group type: COMPARATOR
Intervention: Irbesartan (control)
Number of subjects: 132
Study: 34424893

Group type: EXPERIMENTAL
Intervention: Skinning carcasses of livestock that died suddenly
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Butchering carcasses of livestock that died suddenly
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Carrying carcasses of livestock that died suddenly
Number of subjects: 68
Study: 32077525

Group type: EXPERIMENTAL
Intervention: 2-gene urine-based molecular test for detecting clinically significant prostate cancer (GG ≥ 2)
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: 2-gene urine-based molecular test
Number of subjects: 492

Group type: COMPARATOR
Intervention: ERSPC and PBCG risk calculators
Number of subjects: 492
Study: 33155041

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 30 mL 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham block with 30 mL saline
Number of subjects: 60
Study: 36164194

Group type: EXPERIMENTAL
Intervention: Omidubicel
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard UCB
Number of subjects: 75
Study: 32682856

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine plus 0.25% bupivacaine
Number of subjects: 102

Group type: COMPARATOR
Intervention: 0.25% bupivacaine (control)
Number of subjects: 102
Study: 32884045

Group type: EXPERIMENTAL
Intervention: Spinal Manipulative Therapy (SMT) at the lumbar segment measured as the stiffest
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Spinal Manipulative Therapy (SMT) at the lumbar segment measured as having the lowest pain threshold
Number of subjects: 132

Group type: COMPARATOR
Intervention: Spinal Manipulative Therapy (SMT)
Number of subjects: 132
Study: 34463164

Group type: EXPERIMENTAL
Intervention: ospemifene 60 mg/day for 3 months
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ospemifene 60 mg/day for 6 months
Number of subjects: 100
Study: 36151105

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 25
Study: 33212239

Group type: EXPERIMENTAL
Intervention: Patient self-monitoring via electronic medication monitoring and smartphone application plus remote clinician feedback
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group without feedback
Number of subjects: 100
Study: 33179073

Group type: EXPERIMENTAL
Intervention: Continuous neuroablative radiofrequency (CNARF)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Pulsed neuromodulative radiofrequency (PNMRF)
Number of subjects: 188
Study: 32344728

Group type: EXPERIMENTAL
Intervention: Active re-warm-up in hypoxia (AH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest in normoxia (RN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Active re-warm-up in normoxia (AN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive strategies (RN and RH)
Number of subjects: 10
Study: 34368894

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32605893

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Gefitinib (for EGFR-mutant tumors)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (for EGFR-mutant tumors)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Gefitinib (for EGFR-wild-type tumors)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (for EGFR-wild-type tumors)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 76
Study: 34166539

Group type: EXPERIMENTAL
Intervention: Fully guided (FG) implant surgery
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventionally guided (CG) implant surgery
Number of subjects: 25
Study: 35667481

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study: 33588196

Group type: COMPARATOR
Intervention: CCT
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: CCT + MSST
Number of subjects: 87
Study: 35857100

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 109

Group type: COMPARATOR
Intervention: Clinical model (using clinical factors only)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Radiomics nomogram vs non-survival groups
Number of subjects: 109
Study: 34090604

Group type: EXPERIMENTAL
Intervention: β‐lactam treatment for 3 days
Number of subjects: 0
Study: 32402616

Group type: EXPERIMENTAL
Intervention: γ‐tACS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 34562081

Group type: EXPERIMENTAL
Intervention: Peanuts (28 g/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LFHC snack (whole grain crackers and low-fat cheese)
Number of subjects: 50
Study: 35235636

Group type: EXPERIMENTAL
Intervention: Bicortical fixation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Unicortical fixation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Indirect sinus elevation
Number of subjects: 38
Study: 33620405

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (1.5 g), thiamine (100 mg), and hydrocortisone (50 mg) every 6 hours (n=252)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Matching placebo (n=249)
Number of subjects: 501
Study: 34261691

Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring with FreeStyle Libre 2 (FSL2) for 24 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG) for 24 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: FSL2
Number of subjects: 180

Group type: COMPARATOR
Intervention: SMBG
Number of subjects: 180
Study: 32465908

Group type: EXPERIMENTAL
Intervention: 4 follow-up phone calls within 31 days at intervals of 7-10 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: 1 phone call at the end of the study (control)
Number of subjects: 41
Study: 33447948

Group type: EXPERIMENTAL
Intervention: Telehealth
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control
Number of subjects: 194
Study: 35477621

Group type: EXPERIMENTAL
Intervention: Olanzapine and Samidorphan (OLZ/SAM)
Number of subjects: 0
Study: 33991370

Group type: EXPERIMENTAL
Intervention: Strength training in addition to neuromuscular exercise and education (ST+NEMEX-EDU)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Neuromuscular exercise and education alone (NEMEX-EDU)
Number of subjects: 90
Study: 34610422

Group type: EXPERIMENTAL
Intervention: Genicular artery embolization (GAE)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 21
Study: 34774089

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intermittent negative pressure (INP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham microcurrent (PT)
Number of subjects: 45
Study: 34193407

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32228673

Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine phosphate (TMP)
Number of subjects: 120
Study: 36137125

Group type: EXPERIMENTAL
Intervention: Chemotherapeutic agents (specific agents not detailed)
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Double-blind randomized controlled trials
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Open-label randomized trials
Number of subjects: 755
Study: 35010984

Group type: EXPERIMENTAL
Intervention: 600 mg of bergamot phytosome® and 100 mg of artichoke leaf standardized dry extract
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33068165

Group type: EXPERIMENTAL
Intervention: Uncemented THA
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cemented THA
Number of subjects: 50
Study: 32964693

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral group therapy for recovery of self-esteem (CBGTRS)
Number of subjects: 51
Study: 36412399

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 80

Group type: COMPARATOR
Intervention: 3DCRT
Number of subjects: 80
Study: 33247553

Group type: EXPERIMENTAL
Intervention: Incentive group (200 Rand shopping voucher at Months 2, 3, and 4)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no incentive)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Incentive group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 34053371

Group type: EXPERIMENTAL
Intervention: High-Speed Training (HST)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 24
Study: 32471729

Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 8 weeks after 3 initial doses at baseline and weeks 4 and 8 (Q8)
Number of subjects: 1888

Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 12 weeks after 3 initial doses at baseline and weeks 4 and 12 (Q12)
Number of subjects: 1888

Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks (Q4)
Number of subjects: 1888
Study: 36331089

Group type: EXPERIMENTAL
Intervention: Confucian values intervention
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Taoist values intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Natural science intervention
Number of subjects: 94
Study: 34999543

Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 498
Study: 33627086

Group type: EXPERIMENTAL
Intervention: Interaction with an infant for 30 min
Number of subjects: 102

Group type: COMPARATOR
Intervention: Watching a DVD movie of an infant for 30 min
Number of subjects: 102
Study: 32700098

Group type: EXPERIMENTAL
Intervention: Suspension Training (ST)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 42
Study: 35156069

Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg biannually for a total of four treatments
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 32576776

Group type: EXPERIMENTAL
Intervention: activC prosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bryan disc
Number of subjects: 0
Study: 36183193

Group type: EXPERIMENTAL
Intervention: Gochicoa‐Rangel
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Nowowiejska
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Assumapcao
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Amra
Number of subjects: 227
Study: 34462286

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily for 40 weeks
Number of subjects: 154

Group type: COMPARATOR
Intervention: Chlorthalidone 25 mg once daily for 40 weeks
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 154

Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 154
Study: 32985372

Group type: EXPERIMENTAL
Intervention: Positive imagery cognitive bias modification (CBM) paradigm involving listening to and imagining brief positive imagery scripts
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Emotionally involved manner of imagining scenarios
Number of subjects: 80

Group type: COMPARATOR
Intervention: Emotionally detached manner of imagining scenarios
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exploratory analyses of vivid imagery and recall testing
Number of subjects: 80
Study: 34310072

Group type: EXPERIMENTAL
Intervention: CAET combined with traditional speech and language therapy (SLT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (SLT only)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CAET combined with SLT
Number of subjects: 68
Study: 34708112

Group type: EXPERIMENTAL
Intervention: Chewing menthol gum prior to exercise
Number of subjects: 0
Study: 32791985

Group type: EXPERIMENTAL
Intervention: Xonrid® + SOC
Number of subjects: 80

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 80
Study: 34285006

Group type: EXPERIMENTAL
Intervention: Low-sodium salt substitute intervention
Number of subjects: 0
Study: 32437921

Group type: EXPERIMENTAL
Intervention: Radiation therapy planning according to INSEMA protocol
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Radiation dose in axillary level I
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Radiation dose in axillary levels II and III
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Association between incidental radiation dose and obesity
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Impact of age, boost application, and fractionation schedule
Number of subjects: 276
Study: 35680268

Group type: EXPERIMENTAL
Intervention: NIDUS-Family intervention
Number of subjects: 199
Study: 34218880

Group type: EXPERIMENTAL
Intervention: AI-based ECG model
Number of subjects: 2541

Group type: EXPERIMENTAL
Intervention: Single-lead model (V5)
Number of subjects: 2541

Group type: EXPERIMENTAL
Intervention: 6-lead (bipolar leads) model
Number of subjects: 2541
Study: 32182879

Group type: EXPERIMENTAL
Intervention: BoNT‐A injections into each masseter muscle
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline injections into each masseter muscle (placebo)
Number of subjects: 30
Study: 32278278

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus placebo (PE+PLB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sertraline plus enhanced medication management (SERT+EMM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus Sertraline (PE+SERT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combat exposed controls (CC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotion Regulation Task (ERT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional Faces Assessment Task (EFAT)
Number of subjects: 0
Study: 36017028

Group type: EXPERIMENTAL
Intervention: Surgical therapy combined with VEGF therapy (3 therapies for 1 month/time)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (2 therapies for 1.5 months/time)
Number of subjects: 170